Global Diagnostic Electro Cardiographs Market was worth $ 5434.7 million in 2019 and estimated to be growing at a CAGR of 6.16%, to reach $ 7328.2 million by 2024. Diagnostic Electrocardiograph is a device used to record electrical activity of the heart by placing electrodes on a person’s body.
Technological advancements in communication, low power circuit design for safer ECG devices along with portability features, lower power consumption more accuracy and capacity to incorporate latest diagnostic features are the major factors driving the growth of the market. Increasing aging population and growing incidence of lifestyle diseases are also fuelling the growth of Global Diagnostic Electrocardiographs market. However unstable reimbursement regulations, high cost of devices and economic instability are the major factors hindering the growth of the market.
Global market for Diagnostic Electro Cardiographs is segmented by product, Lead type and End User. On the basis of Product the market is further sub segmented into Resting ECG Systems, Stress ECG Systems and Holter Monitors. By Lead Type market is further sub-segmented into Single-Lead Type ECG Devices, 3–6 Lead Type ECG Devices, 12-Lead Type ECG Devices and Other Lead Type Devices. By End user the market is segmented into Hospitals, Rehabilitation Centers, Home /Ambulatory Care research centers, Diagnostic Centers, Clinics, Physician Offices and surgical centers.
The resting ECG devices segment accounted for the largest share owing to increasing aging population and growing incidence of cardiovascular diseases. Holter diagnostic ECG device is estimated to be the fastest growing segment due to technological advancements, which have brought down the prices of these devices.
On the basis of geography global market for diagnostic electrographs is analyzed under various regions namely North America, Europe, Asia-pacific, Latin America and Middle-East and Africa. North America is the largest market for diagnostic electrocardiographs market due to innovations in technology and wide spread awareness about the advantages of electrocardiographs. Asia-Pacific is estimated to be the fastest growing region due to its high patient base and growing healthcare expenditure.
Some of the major companies covered in the report are BPL Ltd, Cardiac Science Corp, Fukuda Denshi Co., Ltd, GE Healthcare, Medtronic, Inc, Philips Healthcare, Spacelabs Healthcare, Inc, Mortara Instrument, Inc, Midmark Corp, Mindray Medical International Ltd, Nihon Kohden Corp, Scottcare Corp, Schiller Ag, Welch Allyn Inc and Cardionet
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Product
5.1.1 Resting ECG Systems
5.1.2 Stress ECG Systems
5.1.3 Holter Monitors
5.2 By Lead Type
5.2.1 Single-Lead Type ECG Devices
5.2.2 3-6 Lead Type ECG Devices
5.2.3 12-Lead Type ECG Devices
5.2.4 Other Lead Type ECG Devices
5.3 By End User
5.3.1 Hospitals
5.3.2 Home/Ambulatory Care research centres
5.3.3 Diagnostic Centres
5.3.4 Rehabilitation Centres
5.3.5 Clinics
5.3.6 Physician Offices
5.3.7 Surgical Centres
6. Geographical Analysis
6.1 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.2 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.3 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 South Korea
6.4 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Mexico
6.4.4 Rest of Latin America
6.5 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Medtronic, Inc
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Cardiac Science Corp
8.3 BPL Ltd
8.4 Cardionet, Inc
8.5 Fukuda Denshi Co., Ltd
8.6 GE Healthcare
8.7 Midmark Corp
8.8 Mindray Medical International Ltd
8.9 Mortara Instrument, Inc
8.10 Nihon Kohden Corp
8.11 Philips Healthcare
8.12 Scottcare Corp
8.13 Schiller Ag
8.14 Spacelabs Healthcare, Inc
8.15 Welch Allyn Inc
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
